跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Noumed Mirtazapine 45mg Tablet - NPRA Drug Approval Details
Approvals
/
NPRA
/
Noumed Mirtazapine 45mg Tablet
Approved
STANDARD
Noumed Mirtazapine 45mg Tablet
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
aa47cbe182ec4339
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Type
Standard
Approval Details
Approval Id
aa47cbe182ec4339
Drug Approval Npra Name
Noumed Mirtazapine 45mg Tablet
Product Name
Noumed Mirtazapine 45mg Tablet
Registration Number
MAL21066042ACE
Holder Company Name
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Holder Address
1-5, CHENG INDUSTRIAL ESTATE 75250 MALAYSIA
Holder Phone
06-3351515
Manufacturer Company Name
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Manufacturer Address
1-5 CHENG INDUSTRIAL ESTATE 75250 MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL21066042ACE
Version
1751614312
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
aa47cbe182ec4339
Type
Standard
Source
Official Source
Back to NPRA Approvals